Navigation Links
Are New Chemo Treatments Cost-Effective?
Date:3/16/2010

Drug advances extend lives, but one study puts cost per life-year gained at about $66,200

TUESDAY, March 16 (HealthDay News) -- New chemotherapy agents for metastatic colon cancer improve patient survival but are costly, says a new study.

Researchers at Emory University in Atlanta analyzed data from 4,665 patients, aged 66 and older, diagnosed with metastatic colon cancer between 1995 and 2005. Compared to those who received older chemotherapy agents, patients who received one or more of the six chemotherapy agents approved in the United States between 1996 and 2004 lived an average of 6.8 months longer.

That increase in survival was associated with a lifetime cost increase of $37,100, which equates to $66,200 per year of life gained. After they made additional adjustments, the researchers calculated that the cost for each quality-adjusted life-year (a year of life in perfect health) gained was $99,100.

The study was published in the March 16 online edition of the journal Archives of Internal Medicine.

"New chemotherapeutic agents for colorectal cancer have been singled out as examples of high-cost/low-value medical care; no doubt they are the types of therapies that would receive close scrutiny if Medicare and other payers were to consider cost-effectiveness in coverage decisions," wrote David H. Howard and colleagues.

"Our estimate of the cost per quality-adjusted life-year gained, $100,000, is below most estimates of the willingness to pay for a life-year. However, continuation of Medicare's open-ended coverage policy for new chemotherapeutic agents and other expensive technologies will prove difficult to sustain as costs for the program continue to rise," they concluded.

More information

The American Cancer Society has more about col
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Older Colon Cancer Patients Less Likely to Get Chemo
2. Study evaluates costs and benefits of new chemotherapy drugs
3. Scientists identify microRNA as possible cause of chemotherapy resistance
4. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
5. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
6. Patients with resectable esophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy
7. Breast cancer multigene test helping patients avoid chemotherapy
8. Stem Cells Might Reverse Heart Damage From Chemo
9. Herb May Counter Liver Damage From Chemo
10. Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
11. Chemo With Herceptin May Be Best for Some Breast Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , ... July 06, 2015 , ... ... procedures each year for aesthetic reasons, which is why liposuction regularly ranks among ... particular demographic, however, fat reduction has become more than a way to slim ...
(Date:7/6/2015)... ... July 06, 2015 , ... doTERRA, the leading global essential oils ... team. Most recently, Jowers held the position as Director of the Hinckley Institute at ... a decade building the institute, Jowers states that he was ready for a new ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and genomics projects have generated ... to access and use this “Big Data” to improve health and cut costs is ... of the Mount Sinai Health System in New York City. Physicians will have these ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... With a ... teamed up with Livonia Save Our Youth and announced a new charity campaign to ... in regards to alcohol and drug abuse. Livonia Save Our Youth is a coalition ...
(Date:7/6/2015)... Pompano Beach, Florida (PRWEB) , ... July 06, ... ... call center solutions, announced today that Randstad Technologies selected Aspect Software Unified IP ... provider in the United States, selected Aspect Unified IP as its future call ...
Breaking Medicine News(10 mins):Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3
... SuperGen, Inc. (Nasdaq:,SUPG), a pharmaceutical company dedicated to ... announced that James S. Manuso, Ph.D.,President and Chief ... & Renshaw 10th Annual Healthcare Conference on Monday, ... SuperGen,s presentation at the Rodman & Renshaw ...
... who once was a would-be seamstress to the stars, probably likes ... surprising twist: Her granddaughter, Jennifer, is not just dedicating herself to ... CarePages.com, a community of millions of caregivers, patients and their families ... ...
... the Illinois Natural History Survey, a division of the ... mosquitoes are more likely to be infected with viruses ... found in the November issue of the American ... Alto, Ph.D., Director of the Medical Entomology Program at ...
... Mass., Nov. 3 Interleukin Genetics,Inc. (Amex: ... Chief Executive,Officer, will present at the Rodman & ... 2008, at 11:35 am EST. The conference,will be ... New York., A live audio webcast of ...
... just in patient,s head , , MONDAY, Nov. 3 (HealthDay News) ... that makes it more difficult for their brains to settle ... with primary insomnia for more than six months have 30 ... activity in many brain areas, according to the report in ...
... 1 millionth distributor in slumping ... ... million,jobless. 84,000 jobs cut in September alone. A five-year unemployment rate,high of ... worst, or being extremely cautious, at best, direct selling and,XanGo, LLC, are ...
Cached Medicine News:Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 3Health News:Smaller mosquitoes are more likey to be infected with viruses causing human diseases 2Health News:Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Primary Insomnia Tied to Brain Neurochemical Imbalance 2Health News:XanGo, Direct Selling Provide Answers in Economic Downturn 2Health News:XanGo, Direct Selling Provide Answers in Economic Downturn 3
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
(Date:7/6/2015)... 6, 2015   BioClinica®, Inc ., a ... announced that it has acquired a leading global ... Inc. (Medici).  The acquisition includes affiliates MediciGlobal ... also provides a lost-to-follow-up patient locate service ( ... with Medici, BioClinica will offer pharmaceutical ...
(Date:7/6/2015)... DUBLIN, Ohio , July 6, 2015 ... of The Harvard Drug Group (THDG). A distributor of generic ... and alternate care customers, THDG was owned by Court ... all-cash transaction using existing cash and new debt.  ... , The Harvard Drug Group had revenues of approximately ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3
... PRO-DEX, INC. (Nasdaq: PDEX ) will announce results for the Company,s fiscal ... on Thursday, April 29, 2010 after the market closes. , ... Following the release, Pro-Dex will conduct a ... ) to discuss operating performance for the quarter.  Mark Murphy, Chief Executive Officer ...
... PRINCETON, N.J. , April 23 Yesterday, ... first study comparing the once-daily human GLP-1 analog, Victoza® (liraglutide [rDNA] ... Victoza® produced significantly greater reductions in A1C, fasting plasma glucose (FPG), ... satisfaction. , , , ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast 2Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: